SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing
Proceeds will support the completion of SafeHeal's IDE pivotal study and preparation for commercial launch of their lead technology, Colovac®.
PARIS, FRANCE AND TAMPA, FL / ACCESS Newswire / May 6, 2025 / SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced a successful completion of an oversubscribed €35 million Series C equity financing to validate the use of Colovac®, a groundbreaking temporary endoluminal fecal bypass system. Colovac is intended as an alternative to temporary diverting ostomy for patients undergoing colorectal cancer resection.
The proceeds leave SafeHeal well-funded to complete its IDE Pivotal study and accelerate preparation for commercial launch of their lead technology, Colovac.
In conjunction with the financing, Martin Sands and Steven Sands of Solar Eclipse will join as board member and observer respectively.
The Colovac endoluminal bypass system is a less-invasive alternative to temporary diverting ostomy, the current standard of care for patients undergoing colorectal resection. Diverting ostomy is applied prophylactically to most patients today undergoing a low anterior resection (LAR) and anastomosis. The ostomy temporarily diverts the stool away from the healing anastomosis to the outside of the body and into an ostomy bag. In most cases, the ostomy is needed only until the anastomosis has healed, and then it can be reversed, typically after 2-6 months. The eventual reversal of the ostomy requires another operation, with a second hospital stay, recovery period and associated complications. In some cases, the ostomy may not be reversed and becomes permanent. In addition to the potential surgical complications associated with ostomy procedures, patients may experience an impact to their quality of life due to social isolation, reduced physical activity and/or intimacy.
Colovac is an alternative to diverting ostomy, designed to eliminate the need for a temporary stoma in most patients. It aims to improve patient recovery and quality of life by eliminating stoma related complications including permanent stoma and eliminating the physical and emotional burden associated with stoma management and care.
Colovac has been successfully studied in over 100 patients in the U.S., Europe, and Asia and has received FDA Breakthrough Designation status.
'This is a very exciting time at SafeHeal as we continue to achieve a number of critical value-creating milestones in the coming months,' said Chris Richardson, President and Chief Executive Officer. 'We are grateful for the continuing support from Sofinnova Partners and delighted to welcome Solar Eclipse, Gideon and M&L Healthcare, part of M&L Group as new investors. This capital raise places SafeHeal in an excellent position to continue our momentum toward FDA approval and commercialization of Colovac.'
Chris Richardson, President & CEO, SafeHeal
'The current standard of care for treatment of Colon Resection is associated with significant morbidity, risk of permanent stoma and reduced quality of life, driving both the clinical community and regulators to search for better treatment options. SafeHeal is addressing this significant unmet medical need with a highly novel approach,' said Martin Sands of Solar Eclipse. 'I believe SafeHeal's therapeutic platform will dramatically improve quality of life and outcomes for patients with Colon Resections. I look forward to supporting the team to achieve multiple key milestones over the next 18 months.'
'We've been with SafeHeal since day one, when it was born out of our Medtech accelerator, MDStart. Our continued support in this Series C reflects a deep growing belief in their potential to revolutionize care for patients facing ostomy,' said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners.
ABOUT SAFEHEAL®
SafeHeal SAS, headquartered in Paris, France, and its wholly owned U.S. subsidiary, SafeHeal Inc., is a clinical-stage medical device company developing Colovac, a device intended as an alternative to diverting ostomy in patients undergoing colorectal surgery. Colovac is a flexible endoluminal bypass sheath designed to reduce the contact of fecal content at the anastomotic site following colorectal surgery. The device is placed endoluminally and is fully reversible. The device remains in place for 7-10 days, until the body's natural healing and tissue repair processes are complete, after which it is removed during an endoscopic procedure without the need for a second surgical intervention. This enables patients to resume their normal life without the stigma and complications associated with an ostomy procedure. Colovac is an investigational device, not currently available for sale. For more information, please visit www.safeheal.com
MEDIA CONTACTS
USA Scott DePierro Vice President U.S. Operations and Global Business Development, SafeHeal203-444-0279 Europe: Karl-Heinz Blohm Vice President, International, SafeHeal+33 (0) 6 5181 7895
###
SOURCE: SafeHeal
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
11 hours ago
- Business Upturn
Katy Perry vs Justin Trudeau: Who has the higher net worth in 2025?
In 2025, the financial standings of high-profile figures like former Canadian Prime Minister Justin Trudeau and global pop sensation Katy Perry continue to spark curiosity. Both have made headlines recently, not just for their professional achievements but also for a surprising dinner sighting in Montreal that has fueled speculation. This article dives into their estimated net worths in 2025 and compares their sources of wealth. Justin Trudeau's Net Worth in 2025 Justin Trudeau, who served as Canada's Prime Minister from 2015 until his resignation in January 2025, has amassed significant wealth through a combination of family inheritance, political earnings, and savvy investments. According to estimates, Trudeau's net worth in 2025 is approximately $96 million. This figure is bolstered by: Family Wealth : Trudeau inherited a substantial portion of his fortune from his father, former Prime Minister Pierre Trudeau, including real estate and trust funds. : Trudeau inherited a substantial portion of his fortune from his father, former Prime Minister Pierre Trudeau, including real estate and trust funds. Political Career : As Prime Minister, Trudeau earned a salary of around CAD $400,000 annually, supplemented by speaking engagements and book deals post-tenure. : As Prime Minister, Trudeau earned a salary of around CAD $400,000 annually, supplemented by speaking engagements and book deals post-tenure. Investments: His portfolio reportedly includes high-value stocks and luxury properties, contributing significantly to his wealth. Trudeau's financial success is notable, especially considering his relatively modest political salary compared to his overall wealth, much of which stems from inherited assets and strategic investments. Katy Perry's Net Worth in 2025 Katy Perry, the iconic pop star behind hits like Roar and Firework , remains a powerhouse in the entertainment industry. As of 2025, Katy Perry's net worth is estimated at around $400 million, making her one of the wealthiest musicians globally. Her wealth comes from: Music Career : Perry's chart-topping albums, including her 2024 release 143 , and global tours, such as the ongoing Lifetimes Tour , generate millions in revenue. : Perry's chart-topping albums, including her 2024 release , and global tours, such as the ongoing , generate millions in revenue. Brand Endorsements : Partnerships with brands like CoverGirl, H&M, and her own fragrance line have added significantly to her fortune. : Partnerships with brands like CoverGirl, H&M, and her own fragrance line have added significantly to her fortune. Business Ventures : Perry has invested in real estate and owns a stake in various entrepreneurial ventures, further boosting her wealth. : Perry has invested in real estate and owns a stake in various entrepreneurial ventures, further boosting her wealth. American Idol: Her role as a judge on American Idol reportedly earns her $25 million per season, a major contributor to her income. Perry's ability to diversify her income streams beyond music has solidified her financial dominance in the entertainment world. Comparing Net Worths: Trudeau vs. Perry While both Trudeau and Perry are wealthy, Katy Perry's net worth of $400 million far surpasses Justin Trudeau's $96 million. Perry's earnings from her music career, endorsements, and media appearances dwarf Trudeau's wealth, which is largely tied to inheritance and investments rather than active income generation. Perry's global brand and ongoing projects give her a financial edge, while Trudeau's wealth, though substantial, reflects a more static, legacy-driven portfolio. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
CNBC
13 hours ago
- CNBC
Cadence Design Systems is up huge on earnings. What the charts say to do next
There's an old saying in the markets; "The longer the base, the higher in space." Cadence Design Systems 'CDNS' just broke from a 16-month base following a strong earnings report. Sixteen months may not seem that ridiculously extended, but for a company that helps the biggest chip makers in the world design, test, and perfect their chips before they even begin manufacturing, and NVDA higher by 84% in that same 16-month period, I think it's significant. I've been watching this name for some time to add to my portfolio and have owned this in the past, but Tuesday morning's earnings popped the stock out of the base consolidation. I was hesitant to buy this stock up 10% following the report, but looking at the weekly chart you'll see a series of 1-year or greater bases followed by breakouts ranging from 64% to 130%. With room to run, I added a 4% allocation to my Active Opps portfolio this morning and with confirmation that support is holding and buyers continue to push the stock higher, I'll aim for an 8% holding. Notice the GAAP earnings projection below the chart of $4.27 in 2025, but then a 28.9% growth to $5.50. Non-GAAP EPS for 2025 is expected to be $6.75 and then grow to $7.79 in 2026. Top line is also growing nicely at a 11%-19% clip. Moving down to the daily chart you see an up-close look at the range that's been in play since March 2024. I would not be surprised to see a pullback towards $350/$340 and if buyers appear offering the stock support, I'll know there is more institutional money coming to market to get on board the initial missed breakout. Cadence shares essentially a duopoly with Synopsys, Inc (SNPS) in the electronic design automation (EDA) market. This is a high barrier to entry, highly technical segment that is a foundation to the entire semiconductor design market. Their customer base includes Nvidia, AMD , Intel , AMR, Tesla , and Apple and are deeply entrenched in these company's workflows. Jensen Huang, CEO of Nvidia, said that Cadence's Palladium emulation system is indispensable to Nvidia. Apple uses Cadenece's EDA suite in their custom M-series chip and their growing AI infrastructure projects. Moreover, they are diversified from just consumer electronics as they service automotive, aerospace, and AI infrastructure. In our Active Opps portfolio we hold a 4.07% allocation in CDNS established July 29. - Todd Gordon, Founder of Inside Edge Capital , LLC We offer active portfolio management and regular subscriber updates like the idea presented above DISCLOSURES: (Gordon and his firm own CDNS) All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.
UPI
13 hours ago
- UPI
Sales at Kering-owned luxury brand Gucci drop 25%
On Tuesday, France-based Kering, the owner of well-known brands such as Gucci and Balenciaga, reported worse second-quarter financial returns than what was expected. It pointed to "uncertain" global factors. Gucci sales dropped 15% year-on-year to around $4.27 billion versus its projected $4.5 billion. Over the quarter, Gucci sales also went down 25%. File Photo (2021) by John Angelillo/UPI | License Photo July 29 (UPI) -- France-based Kering, the owner of Gucci, on Tuesday reported lower second-quarter financial returns than what was expected, pointing to "uncertain" global factors. Gucci sales dropped 15% year-on-year to about $4.27 billion versus its projected $4.5 billion. Over the quarter, sales at the Italian luxury brand also went down 25%. "Though the numbers we are reporting remain well below our potential, we are certain that our comprehensive efforts of the past two years have set healthy foundations for the next stages in Kering's development," company Chairman and CEO François-Henri Pinault said in a statement acknowledging the disappointing numbers. Stock value in Kering fell nearly a quarter in the past year alone. Kering, which owns other brands such as Bottega Veneta and Saint Laurent, noted that sales were weaker across the board primarily in Japan and the Asia-Pacific region. Saint Laurent, the second-largest Kering-owned brand, also saw sales down by 10% in the quarter. On Tuesday, Kering's CFO Armelle Poulou told the Financial Times that sales in Gucci improved among North American consumers. She added its Bottega eyewear division had grown by a single digit. The company says in an economic and geopolitical environment that "remains uncertain," it continues to "deploy its strategy with the aim of achieving a profitable long-term growth trajectory." In an email, Third Bridge analyst Yanmei Tang told CNBC that Kering is facing a "tough reality as its two main luxury markets, China and the United States, are under strain." The French luxury group announced in 2021 that it banned the use of animal fur across all Kering-owned companies.
